A pioneering collaboration between Omnigene Medical Technologies Ltd and the University of Malta is developing a liquid biopsy platform that could transform how cancer is monitored. Called M3Profiler, the technology analyses tumour-derived exosomes – tiny vesicles released into the bloodstream by cancer cells – to generate detailed molecular profiles from just a small blood sample.
Continue reading
At the European Society of Oncologic Imaging (ESOI) Touchdown 2025 in Malta, radiologists and imaging specialists from around the world gathered to explore not just the science of oncologic imaging, but its soul. In a field defined by technology and precision, last year’s focus turned inward – to the art of communication, empathy, and the enduring humanity that binds medicine together.
Continue reading